Lettieri S, Bertuccio F, Del Frate L, Perrotta F, Corsico A, Stella G
Int J Mol Sci. 2024; 25(1).
PMID: 38203718
PMC: 10779349.
DOI: 10.3390/ijms25010547.
Zhang Y, Gan Y, Zhang H
BMC Pulm Med. 2023; 23(1):376.
PMID: 37803281
PMC: 10559423.
DOI: 10.1186/s12890-023-02673-4.
Hasselbalch H, Junker P, Skov V, Kjaer L, Knudsen T, Larsen M
Cancers (Basel). 2023; 15(17).
PMID: 37686599
PMC: 10486581.
DOI: 10.3390/cancers15174323.
Suzuki K, Kim J, Ugai K, Matsuda S, Mikami H, Yoshioka K
Mol Med Rep. 2020; 22(2):1518-1526.
PMID: 32626975
PMC: 7339813.
DOI: 10.3892/mmr.2020.11218.
Sugino K, Nakamura Y, Muramatsu Y, Hata Y, Shibuya K, Homma S
Mol Clin Oncol. 2016; 5(4):402-406.
PMID: 27699034
PMC: 5038165.
DOI: 10.3892/mco.2016.993.
Mesenchymal stem cells protect against the tissue fibrosis of ketamine-induced cystitis in rat bladder.
Kim A, Yu H, Heo J, Song M, Shin J, Lim J
Sci Rep. 2016; 6:30881.
PMID: 27481042
PMC: 4969614.
DOI: 10.1038/srep30881.
New therapeutic targets in idiopathic pulmonary fibrosis. Aiming to rein in runaway wound-healing responses.
Ahluwalia N, Shea B, Tager A
Am J Respir Crit Care Med. 2014; 190(8):867-78.
PMID: 25090037
PMC: 4299574.
DOI: 10.1164/rccm.201403-0509PP.
Corilagin attenuates aerosol bleomycin-induced experimental lung injury.
Wang Z, Guo Q, Zhang X, Li X, Li W, Ma X
Int J Mol Sci. 2014; 15(6):9762-79.
PMID: 24886817
PMC: 4100119.
DOI: 10.3390/ijms15069762.
Where do we stand with IPF treatment?.
Albera C, Ferrero C, Rindone E, Zanotto S, Rizza E
Respir Res. 2013; 14 Suppl 1:S7.
PMID: 23734956
PMC: 3643087.
DOI: 10.1186/1465-9921-14-S1-S7.
Evidence-based treatment strategies in idiopathic pulmonary fibrosis.
Behr J
Eur Respir Rev. 2013; 22(128):163-8.
PMID: 23728871
PMC: 9487376.
DOI: 10.1183/09059180.00001013.
Current and novel drug therapies for idiopathic pulmonary fibrosis.
Adamali H, Maher T
Drug Des Devel Ther. 2012; 6:261-72.
PMID: 23055696
PMC: 3463380.
DOI: 10.2147/DDDT.S29928.
New insights into the role of oxidative stress in scleroderma fibrosis.
Gabrielli A, Svegliati S, Moroncini G, Amico D
Open Rheumatol J. 2012; 6:87-95.
PMID: 22802906
PMC: 3395898.
DOI: 10.2174/1874312901206010087.
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Raghu G, Anstrom K, King Jr T, Lasky J, Martinez F
N Engl J Med. 2012; 366(21):1968-77.
PMID: 22607134
PMC: 3422642.
DOI: 10.1056/NEJMoa1113354.
Apoptosis and the airway epithelium.
White S
J Allergy (Cairo). 2011; 2011:948406.
PMID: 22203854
PMC: 3238401.
DOI: 10.1155/2011/948406.
Therapeutic value of small molecule inhibitor to plasminogen activator inhibitor-1 for lung fibrosis.
Huang W, Vayalil P, Miyata T, Hagood J, Liu R
Am J Respir Cell Mol Biol. 2011; 46(1):87-95.
PMID: 21852684
PMC: 3262658.
DOI: 10.1165/rcmb.2011-0139OC.
Postoperative Acute Exacerbation of IPF after Lung Resection for Primary Lung Cancer.
Watanabe A, Kawaharada N, Higami T
Pulm Med. 2011; 2011:960316.
PMID: 21637373
PMC: 3100115.
DOI: 10.1155/2011/960316.
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Raghu G, Collard H, Egan J, Martinez F, Behr J, Brown K
Am J Respir Crit Care Med. 2011; 183(6):788-824.
PMID: 21471066
PMC: 5450933.
DOI: 10.1164/rccm.2009-040GL.
A key role for NOX4 in epithelial cell death during development of lung fibrosis.
Carnesecchi S, Deffert C, Donati Y, Basset O, Hinz B, Preynat-Seauve O
Antioxid Redox Signal. 2011; 15(3):607-19.
PMID: 21391892
PMC: 3163392.
DOI: 10.1089/ars.2010.3829.
Lung function in idiopathic pulmonary fibrosis--extended analyses of the IFIGENIA trial.
Behr J, Demedts M, Buhl R, Costabel U, Dekhuijzen R, Jansen H
Respir Res. 2009; 10:101.
PMID: 19860915
PMC: 2774307.
DOI: 10.1186/1465-9921-10-101.
Oxidative stress and glutathione in TGF-beta-mediated fibrogenesis.
Liu R, Gaston Pravia K
Free Radic Biol Med. 2009; 48(1):1-15.
PMID: 19800967
PMC: 2818240.
DOI: 10.1016/j.freeradbiomed.2009.09.026.
